HELE Shorts Creep Higher as Analysts Stay Cautious

Helen of Troy heads into the week with short sellers quietly adding to positions, options traders tilting bullish, and a Street consensus that is neutral at best.

Short interest has edged up for a third consecutive week, reaching 11.5% of the free float on November 3. That is up 4.3% over the past seven days and marks a steady rebuild after a sharp drop in mid-October, when positions fell from above 11.9% to roughly 9.3% in the space of a few sessions. The monthly trend still shows a 6.2% decline, so the week-on-week move is more of a re-accumulation than a new wave. Importantly, the borrow market carries none of the tension that typically accompanies a high short interest reading. Cost to borrow has fallen 35% over the past week to just 0.53%, a low-end level that reflects how easy it remains to put on a short. Availability is exceptionally loose at 842%, meaning there are roughly eight shares available to borrow for every one already on loan. That cushion makes a mechanically driven short squeeze look distant under current lending conditions.

Options positioning presents the clearest divergence from the short interest picture. The put/call ratio has drifted to 0.71, nearly two standard deviations below its 20-day average of 0.74, sitting close to its 52-week low of 0.57. That is unusually call-heavy relative to recent norms, suggesting options participants are positioning more for upside than for protection. The two markets are sending opposite signals: short sellers are adding shares to borrow, while options traders are buying into calls.

The Street sits firmly on the fence. The only active coverage comes from UBS, which carries a Neutral rating with a $29 target after raising it from $28 on October 9, and Canaccord Genuity, which maintained its Hold at $26 following the same October earnings event. The consensus mean target of around $31.70 sits only modestly above the current price of $29.54. Valuation multiples frame the stock as cheap by conventional measures: the price-to-earnings ratio has expanded to roughly 7.3 over the past 30 days, with EV/EBITDA at 7.3 and price-to-book below 0.7. The earnings yield factor ranks in the 87th percentile, one of the stronger scores in the snapshot. The bear case centres on a projected 10% sales decline from softer demand in beverageware and home goods, compounded by tariff-driven cancellations of direct import orders. The bull case rests on point-of-sale unit growth across eight of eleven core brands, selective price increases, and potential recovery in the cold and flu season for health-related product lines.

One element from the company's own SEC filings is worth noting. Helen of Troy's remaining buyback authorisation has fallen for six consecutive quarters, reaching $496.8 million as of the April quarter. At the same time, shares repurchased are down 69% against the equivalent period from the prior year. That combination, an authorisation that keeps shrinking while buyback activity collapses, reduces one potential source of technical support for the share price.

The most recent earnings event in early October produced a one-day gain of roughly 3.8% and a five-day move of 15.6%, a strong post-earnings reaction that has carried the stock up around 10% over the past month. With no next earnings date yet in the data, the question for the week ahead is whether the modest short interest rebuild and the gap between the two analyst targets and the current price tighten or widen as macro pressure on consumer staples-adjacent names continues to play out.